Related Experiment Videos
Modulation of paraoxonase (PON1) activity.
Lucio G Costa1, Annabella Vitalone, Toby B Cole
1Department of Environmental and Occupational Health Sciences, University of Washington, 4225 Roosevelt Way NE, Suite 100, Seattle, WA 98105, USA. lgcosta@u.washington.edu
Biochemical Pharmacology
|January 27, 2005
Summary
Paraoxonase 1 (PON1) is a serum enzyme that defends against organophosphate toxicity and cardiovascular disease. Environmental factors and genetic variations significantly influence PON1 activity, impacting its protective functions.
Area of Science:
- Biochemistry
- Toxicology
- Genetics
Background:
- Paraoxonase 1 (PON1) is a serum enzyme linked to high-density lipoprotein (HDL).
- PON1 hydrolyzes organophosphorus compounds, metabolizes oxidized lipids, and affects drug metabolism.
- Significant inter-individual variation in PON1 activity exists, influenced by genetic polymorphisms.
Purpose of the Study:
- To examine major factors modulating serum PON1 activity.
- To understand the toxicological and clinical implications of PON1 modulation.
- To highlight the role of PON1 in organophosphate toxicity and cardiovascular disease.
Main Methods:
- Literature review of factors affecting PON1 activity.
- Analysis of genetic polymorphisms (Q192R, T-108C) and their impact.
- Examination of environmental, lifestyle, and disease-related modulators.
Main Results:
- Serum PON1 activity varies up to 40-fold among individuals.
- Genetic polymorphisms explain a significant portion of this variation.
- Environmental chemicals, drugs, smoking, alcohol, diet, age, and diseases also modulate PON1 activity.
Conclusions:
- PON1 activity is influenced by a complex interplay of genetic and environmental factors.
- Understanding PON1 modulation is crucial for managing organophosphate exposure and cardiovascular risk.
- Further research into newly discovered polymorphisms and their effects is warranted.